Notice of Completion of Payment for the Issuance of Noile-Immune Biotech Inc. 14th Stock Acquisition Rights (with Exercise Price Adjustment Clause) by Third-Party Allotment

Notification of Issuance of Stock Acquisition Rights and Completion of Payment

Noile-Immune Biotech Inc. has announced that payment for the 14th series of stock acquisition rights issued by third-party allotment has been completed. As a summary of the offering, the number of stock acquisition rights issued is 100,000 units, the issue price is 14 yen per unit (total 1,400,000 yen), and the number of potential shares is 10,000,000 shares. The adjusted reference price is calculated based on 95% of the Tokyo Stock Exchange closing price, and the lower exercise price is 81 yen. The amount of funds to be raised is estimated at a total of 1,349,400,000 yen, and the allottee is Okasan Securities Co., Ltd. Lock-up and other conditions are also included in the agreement.

Allotment, Exercise Period and Conditions

These stock acquisition rights have an exercise period set from the banking business day following the allotment date until October 5, 2028, and the third-party allotment agreement includes constraints such as exercise restriction periods, lock-up, and transfer approval. The actual amount of funds raised may vary depending on the level of exercise prices, and the final fundraising amount will increase or decrease depending on whether the rights are exercised.